Armata Pharmaceuticals Inc
Armata Pharmaceuticals Inc (ARMP) Covered Calls
No qualifying covered call setups were found for ARMP in the prior session.
Read more
Running ARMP covered calls helps you generate consistent income from Armata Pharmaceuticals Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Armata Pharmaceuticals Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best ARMP covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if ARMP stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling ARMP covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Armata Pharmaceuticals Inc covered call is worth writing.
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
Income-focused investors, long-term ARMP holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling ARMP covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Armata Pharmaceuticals Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile57.94% Neutral
- Market cap (M$)139
- 52 weeks high-77.11%
- 52 weeks low27.21%
- Analyst recommendationStrong Buy
1.00 - Target price$17.50
362.96% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E—
- Future P/E—
- EPS (ttm)-7.59
- EPS growth next 5 years38.99%
As of September 25, 2026
No illustrative rows to display.
As of September 25, 2026
Sell covered calls with the data behind you
Find the best ARMP covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→